Twinbeech Capital LP Ptc Therapeutics, Inc. Transaction History

Twinbeech Capital LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $912,344 - $1.48 Million	36,952 New	36,952 $1.13 Million
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $2.26 Million - $3.67 Million	-124,843 Reduced 64.85%	67,679 $1.87 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $3.44 Million - $6.44 Million	153,304 Added 390.9%	192,522 $4.31 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $1.58 Million - $2.32 Million	39,218 New	39,218 $1.59 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $732,128 - $866,711	-20,705 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $766,292 - $926,341	20,705 New	20,705 $770,000
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $285,105 - $419,860	-6,092 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $292,172 - $412,062	6,092 New	6,092 $372,000
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $501,186 - $647,444	-11,776 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $381,189 - $699,023	11,776 New	11,776 $525,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.